Nuformix (LSE:NFX) Net Income (Continuing Operations) : £-3.78 Mil (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Nuformix's Net Income (Continuing Operations) for the six months ended in Mar. 2025 was £-0.38 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was £-3.78 Mil.

Nuformix Net Income (Continuing Operations) Historical Data

The historical data trend for Nuformix's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Net Income (Continuing Operations) Chart

Nuformix Annual Data

Trend

Dec15

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Sep24

Net Income (Continuing Operations)

Get a 7-Day Free Trial

-0.76

-1.25

-1.11

-0.76

-3.64

Nuformix Semi-Annual Data
	Dec15	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Mar24	Sep24	Mar25
Net Income (Continuing Operations)	Get a 7-Day Free Trial													-0.42	-0.34	-0.24	-3.40	-0.38

Nuformix Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-3.78 Mil.

Nuformix (LSE:NFX) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Nuformix Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Nuformix's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.